Original articles: Clinical responses to topical photo-dynamic therapy of actinic keratoses, bowen's disease and non-oncological diseases in japan

Laser Therapy

Volumn 19, Issue 3, 2010, Pages 159-166

  Matsumoto, Yoshinari ^a   Akita, Yoichi ^a   Nakaseko, Hirono ^a   Kawamura, Chiharu ^a   Nakano, Aki ^a   Watanabe, Daisuke ^a   Tamada, Yasuhiko ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 aminolevulinic acid (ALA); actinic keratoses (AK); Bowen s disease (BD); non oncological skin diseases; Photodynamic therapy (PDT)

Indexed keywords

EID: 84860449643     PISSN: 08985901     EISSN: None     Source Type: Journal    
DOI: 10.5978/islsm.19.159     Document Type: Article

References (28)

1. Pass H.I. (1993): Photodynamic therapy in oncology. Mechanisms and clinical use, Journal of the National Cancer Institute, 85: 443-456.
2. Morton C.A., McKenna K.E., Rhodes L.E. (2008): Guidelines for topical photodynamic therapy: update, British Journal of Dermatology, 159: 1245-1266.
3. Kennedy J.C. Pottier R.H., Pross D.C. (1990): Photodynamic therapy with endogenous protopor-phyrin IX; basic principles and present clinical experience. Journal of Photochemistry and Photobiology B: Biology, 6: 143-148.
4. Morton C.A., Brown S.B., Collins S., Ibbotson S., Jenkinson H., Kurwa H., Langmack K., Mckenna K., Moseley H., Pearse A.D., Stringer M., Taylor D.K., Wong G., Rhodes L.E. (2002): Guideline for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. British Journal of Dermatology, 146: 552-567.
5. Braathen L.R., Szeimies R.-M., Basset-Seguin N., Bissonnette R., Foley P., Pariser D., Roelandts R., Wennberg A.-M., Morton C.A. (2007): Guideline on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. The Journal of American Academy of Dermatology, 56: 125-143.
6. Szeimies R.M., Karrer S., Radakovic-Fijan S., Tanew A., Calzavara-Pinton P.G., Zane C., Sidoroff A., Hempel M., Ulrich J. Proebstle T., Meffert H., Mulder M., Salomon D., Dittmar H.C. Bauer J.W., Kernland K. Braathen L. (2002): Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. The Journal of American Academy of Dermatology, 47: 258-262.
7. Parister D.M., Lowe N.J., Stewart D.M., Jarrat M.T., Lucky A.W., Parister R.J., et al (2003); Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. The Journal of American Academy of Dermatology, 48: 227-232.
8. Freeman M., Vinciullo C., Francis D., Spelman L., Nauven R., Ferain P., Thai K.E., Murrell D., Weightman W., Anderson C., Reid C., Watson A., Foley P. (2003): A comparison of photodynamic therapy using topical methyl 5-aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. The Journal of Dermatological Treatment, 14: 99-106.
9. Moloney F.J., Collins P. (2007): Randomized double blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. British Journal of Dermatology, 157: 87-91.
10. Itoh Y., Ninomiya Y. Henta T., Henta T. Tajima S., Ishibashi A. (2000): Topical d-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses. The Journal of Dermatology, 27: 513-518.
11. Nakano A., Y. Tamada, Watanabe D., Ishida N., Yamashita N., Kuhara T., Yanagishita T., Kawamura C., Akita Y., Matsumoto Y. (2009): A pilot study to assess the efficacy of photodynamic therapy for Japanese patients with actinic keratosis in relation to lesion size and histological severity. Photodermatology Photoimmunology photomedicine, 25: 37-40.
12. Klein A., Babilas P., Karrer S., Landthaler M. Szeimies R.-M. (2008); Photodynamic therapy in dermatol-ogy-an update, Journal der Deutschen Dermatologischen Gesellscaft, 6: 1-7.
13. Nakaseko H., Kobayashi M., Akita Y., Tamada Y., Matsumoto Y. (2003): Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses, British Journal of Dermatology, 148: 122-127.
14. Kodama M., Wtanabe D., Akita Y., Tamada Y., Matsumoto Y. (2007): Photodynamic therapy for the treatment of actinic cheilitis, Photodermatology Photoimmunology Photomedicine, 23: 209-210.
15. Mikasa K. Watanabe D., Kondo C., Kobayashi M., Nakaseko H., Yokoo K., Tamada Y., Matsumoto Y (2005): 5-aminolevulinic acid-based photodynamic therapy for the treatment of two patients with extramammary Paget’s disease, The Journal of Dermatology, 32: 97-101.
16. Fukui T., Watanabe D., Tamada Y., Matsumoto Y (2009): Photodynamic therapy following carbon dioxide laser enhances efficacy in the treatment of extramammary Paget’s disease, Acta Dermato-Venereologica, 89: 150-154.
17. Kondo T., Nakaseko H., Kobayasi M., Mikasa K., Tamada Y., Matsumoto Y. (2003): Topical 5-aminolevulinic acid-based photodynamic therapy for mycosis fungoides, Japanese Journal of Dermatology, 113: 1535-1539.
18. Kondo C., Nakaseko H., Kobayashi M., Mikasa K., Tamada Y., Matsumoto Y (2004): Topical 5-aminolevulinic acid-based photodynamic therapy for sarcoidosis, Japanese Journal of Dermatology 114: 1777-1780.
19. Kondo C., Watanabe D., Nakaseko H., Morisita M., Tsuboi T., Tamada Y., Matsumoto Y. (2006): Photodynamic therapy for recurrent sarcoid flexor tenosynovitis of the finger. The Journal of American Academy of Dermatology, 55: S99-S101.
20. Nakaseko H., Tamada Y., Matsumoto Y. (2002); Photodynamic therapy with topical 5-aminolevulin-ic acid for recalcitrant warts, Japanese Journal of Dermatology 102; 37-41.
21. Watanabe D., Kawamura C., Masuda Y., Akita Y., Tamada y., Matsumoto Y. (2008); Successful treatment of toenail onychomycosis with photodynamic therapy, Archives of Dermatology, 144: 19-21.
22. Mikasa K., Wtanabe D., Kondo C., Tamada Y., Matsumoto Y. (2005): Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma, The Journal of American Academy of Dermatology, 53: 911-912.
23. Pariser D., Loss R., Jarratt M. et al. (2008): Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, doubleblind, placebocontrolled study. The Journal of American Academy of Dermatology, 59: 569-576.
24. Kuhara T., Watanabe D., Akita Y., Takeo T., Ishida N., Nakano A., Yamashita N., Ohshima Y., Kawada M., Yanagishita T., Tamada Y., Matsumoto Y. (2008): Thioredoxin upregulation by 5-aminolaevulinic acid-based photodynamic therapy in human skin squamous cell carcinoma cell line. Photodermatology Photoimmunology photomedicine, 24: 142-146.
25. Akita Y., Kozaki K., Nakagawa A., Saito T., Ito S., Tamada Y., Fujiwara S. Nishikawa N., Uchida K., Yoshikawa K., Noguchi T., Miyaishi O. Shimozato K. Saga S., Matsumoto Y. (2004): Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity, British Journal of Dermatology. 151: 472-480.
26. Ishida N., Watanabe D., Akita Y., Nakano A., Yamashita T., Kuhara T., Yanagishita T., Takeo T., Tamada Y., Matsumoto Y. (2008): Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminlaevulic acid-based photodynamic therapy, Clinical and experimental dermatology, 34: 385-389.
27. Akita Y., Kozaki K., Takeo T., Ohmura M., Nakagawa A., Yanagishita T., Kazaoka Y., Nozaki T., Yokoo K., Shinohara M., Watanabe D., Kawai T., Yamada S., Tamada Y., Ohura K., Matsumoto Y. (2006): Enhancement of photodynamic effects on human oral squamous cell carcinoma cell lines by treatment with calcipotriol. Journal of Dermatological Science, 2: S57-S64.
28. Clark C., Bryden A., Dawe R., Moseley H., Ferguson J., Ibbotson S.H. (2003): Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatology Photoimmunology photomedicine, 19: 134-141.